首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1601806

消费者基因组学市场 - 全球产业规模、份额、趋势、机会和预测，按应用、地区和竞争细分，2019-2029F

Consumer Genomics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Application, By Region and Competition, 2019-2029F

出版日期: 2024年11月30日 | 出版商:

TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年全球消费者基因组市值为12.6亿美元，预计2029年将达到36.7亿美元，预测期间内复合年增长率为19.68%。全球消费者基因组学市场已成为医疗保健、遗传学和个人化健康领域的一股变革力量，为个人提供了前所未有的获取遗传资讯和了解其血统、健康倾向和特征的机会。这个新兴市场的特点是提供直接面向消费者 (DTC) 的基因检测服务，在基因组技术进步、测序成本下降以及消费者对遗传学的认识和兴趣不断提高的推动下，该市场呈指数级增长。该市场涵盖广泛的产品，从血统和谱系测试到健康和保健评估、药物基因组学和以生活方式为导向的遗传见解。

市场概况
预测期	2025-2029
2023 年市场规模	12.6亿美元
2029 年市场规模	36.7亿美元
2024-2029 年复合年增长率	19.68%
成长最快的细分市场	生活方式健康与营养
最大的市场	北美洲

这些测试通常涉及收集唾液或脸颊拭子样本，然后进行分析以产生综合报告，详细说明血统组成、疾病的遗传倾向、遗传状况的携带者状态以及对某些药物的反应。除了满足人们对遗传的好奇心之外，消费者基因组学对医疗保健也具有重大影响，有助于积极主动的疾病预防、个人化治疗策略以及有关生活方式选择、营养和健身方案的明智决策。

遗传资料与数位健康平台、穿戴式装置和远距医疗服务的集成，为针对个人遗传图谱量身定制的个人化医疗方法铺平了道路，从而彻底改变了传统的医疗保健范式。然而，消费者基因组学的广泛采用引发了伦理、隐私和监管方面的担忧，涉及基因资料的保密性和安全性、测试结果的准确性和解释、遗传风险披露的潜在心理影响以及透过测试实现基因组资讯的商业化。例如，2022 年10 月，韩国GC Biopharma 的子公司GC LabTech（经过CAP 和ISO 认证的FDA 註册专业实验室，专门挽救生命的血浆测试）选择了1health.io，这是一家改变产业格局的先锋软体公司透过将服务扩展到国内市场，促进将其尖端实验室测试直接交付给消费者，从而扩大实验室测试的影响力。

消费者基因组学公司、製药公司、研究机构和医疗保健提供者之间的合作正在促进创新并推动精准肿瘤学、罕见疾病诊断和人口健康管理等领域新颖应用的开发。新兴市场消费者基因组学的普及以及对个人化医疗解决方案不断增长的需求，将推动市场进一步扩张，并推动未来几年的持续成长。

主要市场驱动因素

基因组技术和定序方法不断取得进展

消费者对遗传学、健康和保健的兴趣和意识不断增长

消费者基因体学与数位健康科技的融合

主要市场挑战

驾驭监管环境

确保资料隐私和安全

解决道德和社会影响

主要市场趋势

技术进步

个性化医疗保健的扩展

细分市场洞察

应用洞察

区域洞察

Global Consumer Genomics Market was valued at USD 1.26 billion in 2023 and is expected to reach USD 3.67 Billion by 2029 with a CAGR of 19.68% during the forecast period. The Global Consumer Genomics Market has emerged as a transformative force in healthcare, genetics, and personalized wellness, offering individuals unprecedented access to their genetic information and insights into their ancestry, health predispositions, and traits. This burgeoning market, characterized by the provision of direct-to-consumer (DTC) genetic testing services, has witnessed exponential growth driven by advancements in genomic technologies, declining sequencing costs, and increasing consumer awareness and interest in genetics. The market encompasses a wide array of offerings, ranging from ancestry and genealogy tests to health and wellness assessments, pharmacogenomics, and lifestyle-oriented genetic insights.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 1.26 Billion
Market Size 2029	USD 3.67 Billion
CAGR 2024-2029	19.68%
Fastest Growing Segment	Lifestyle Wellness & Nutrition
Largest Market	North America

These tests typically involve the collection of a saliva or cheek swab sample, which is then analyzed to generate comprehensive reports detailing ancestry composition, genetic predispositions to diseases, carrier status for genetic conditions, and response to certain medications. Beyond satisfying curiosity about one's genetic heritage, consumer genomics has significant implications for healthcare, facilitating proactive disease prevention, personalized treatment strategies, and informed decision-making regarding lifestyle choices, nutrition, and fitness regimens.

The integration of genetic data with digital health platforms, wearable devices, and telemedicine services has paved the way for personalized medicine approaches tailored to individual genetic profiles, thereby revolutionizing traditional healthcare paradigms. However, the widespread adoption of consumer genomics has raised ethical, privacy, and regulatory concerns regarding the confidentiality and security of genetic data, the accuracy and interpretation of test results, potential psychological impacts of genetic risk disclosures, and the commercialization of genomic information by testing companies. For instance, In October 2022, GC LabTech, a subsidiary of GC Biopharma based in South Korea, a CAP & ISO accredited FDA-registered specialty laboratory specializing in life-saving plasma tests, chose 1health.io, a pioneering software company transforming the landscape of laboratory testing by extending services to the at-home market, to facilitate the delivery of its cutting-edge laboratory tests directly to consumers.

Collaborations between consumer genomics companies, pharmaceutical firms, research institutions, and healthcare providers are fostering innovation and driving the development of novel applications in areas like precision oncology, rare disease diagnosis, and population health management. Expanding access to consumer genomics in emerging markets and the growing demand for personalized healthcare solutions are poised to fuel further market expansion and drive sustained growth in the coming years.

Key Market Drivers

Growing Progress in Genomic Technologies and Sequencing Methodologies

The Global Consumer Genomics Market is experiencing a significant boost from the growing progress in genomic technologies and sequencing methodologies, which are driving unprecedented advancements in genetic testing accessibility, affordability, and accuracy. One of the primary drivers of market growth is the emergence of next-generation sequencing (NGS) platforms, which have revolutionized the field of genomics by enabling high-throughput, cost-effective sequencing of large volumes of genetic data. Unlike traditional Sanger sequencing methods, NGS technologies leverage parallel sequencing of millions of DNA fragments, significantly reducing sequencing costs and turnaround times. This technological breakthrough has democratized access to genetic testing, allowing consumer genomics companies to offer comprehensive DNA analysis at a fraction of the cost, making it accessible to a broader segment of the population.

Advancements in sequencing methodologies, such as whole-genome sequencing (WGS) and whole-exome sequencing (WES), have expanded the scope and depth of genetic analysis, enabling the identification of rare variants, structural variations, and complex genetic interactions associated with disease risk and treatment response. These techniques provide consumers with a more comprehensive view of their genetic makeup, enhancing the utility and value of consumer genomics products and services.For instance, In 2021, myDNA, a prominent Australian genomics company, revealed its merger with the U.S.-based consumer DNA testing company FamilyTreeDNA and its parent organization, Gene by Gene, headquartered in Houston.

The development of miniaturized, portable sequencing devices and point-of-care testing platforms is further driving market growth by enabling real-time, on-demand genetic testing in diverse settings, including clinics, pharmacies, and even home environments. These handheld devices offer rapid sample-to-answer capabilities, making genetic testing more convenient, accessible, and scalable, particularly in remote or underserved regions where access to traditional laboratory-based testing facilities may be limited.

Advancements in bioinformatics and data analysis algorithms are enhancing the interpretation and actionable insights derived from genetic data, enabling consumer genomics companies to provide more personalized and accurate reports to consumers. Machine learning and artificial intelligence (AI) techniques are being increasingly utilized to analyze vast genomic datasets, identify disease associations, and predict individual health risks, further driving the adoption of consumer genomics for personalized healthcare and wellness management.

Growing Consumer Interest and Awareness of Genetics, Health, And Wellness

The Global Consumer Genomics Market is experiencing a significant boost from the growing consumer interest and awareness of genetics, health, and wellness, driving increased demand for personalized genetic testing and insights. In recent years, there has been a notable shift in consumer attitudes towards healthcare, with individuals becoming more proactive in managing their health and seeking personalized solutions based on their genetic makeup. One of the primary drivers of market growth is the increasing public awareness of the role genetics plays in health and disease. With the rise of personalized medicine and the growing body of research linking genetic variants to various health conditions, consumers are increasingly recognizing the value of genetic testing in understanding their individual health risks and making informed decisions about preventive measures and treatment options. Media coverage, educational campaigns, and celebrity endorsements have also contributed to raising awareness of consumer genomics, making genetic testing more mainstream and accessible to a broader audience.

The popularity of direct-to-consumer (DTC) genetic testing services offered by companies like 23andMe, AncestryDNA, and MyHeritage has fueled consumer interest in exploring their genetic ancestry, traits, and predispositions to diseases. These companies offer easy-to-use DNA testing kits that enable individuals to collect a saliva or cheek swab sample at home and receive comprehensive reports detailing their ancestry composition, genetic health risks, carrier status for inherited conditions, and other genetic insights. The convenience, affordability, and privacy of DTC genetic testing have contributed to its widespread adoption among consumers seeking to unlock the secrets of their genetic code.

The growing focus on preventive healthcare and wellness optimization has spurred interest in leveraging genetic information to tailor lifestyle choices, nutrition plans, and fitness regimens to individual genetic profiles. Consumers are increasingly turning to consumer genomics to gain insights into their genetic predispositions for traits like metabolism, response to exercise, and dietary preferences, empowering them to make informed decisions about their health and well-being. This growing demand for personalized wellness solutions is driving market expansion and diversification, with consumer genomics companies offering a wide range of health and wellness-oriented genetic tests and services to cater to diverse consumer needs and preferences.

Convergence Of Consumer Genomics with Digital Health Technologies

The convergence of consumer genomics with digital health technologies is playing a pivotal role in boosting the Global Consumer Genomics Market, driving innovation, and expanding the scope of personalized healthcare delivery. This synergy between genomics and digital health is revolutionizing the way genetic information is collected, analyzed, and utilized to empower individuals in managing their health and well-being. One of the key drivers of market growth is the integration of genetic data with electronic health records (EHRs) and other digital health platforms, enabling seamless interoperability and data sharing between healthcare providers and consumer genomics companies. This integration facilitates the incorporation of genetic information into routine healthcare workflows, allowing clinicians to access and interpret genetic test results alongside other clinical data to inform diagnosis, treatment decisions, and disease management strategies. By leveraging digital health technologies, consumer genomics companies can enhance the clinical utility and relevance of genetic testing, thereby driving adoption among healthcare professionals and improving patient outcomes.

Wearable devices and mobile health applications are increasingly being utilized to collect real-time health data, lifestyle behaviors, and environmental factors, which can be integrated with genetic information to provide more holistic and personalized health insights to consumers. Wearable sensors, such as fitness trackers, smartwatches, and biosensors, enable continuous monitoring of physiological parameters like heart rate, activity levels, sleep patterns, and stress responses, complementing genetic data to offer a comprehensive view of an individual's health status and risk factors. By combining genetic and lifestyle data, consumer genomics companies can deliver more tailored and actionable recommendations for disease prevention, wellness optimization, and behavior modification, empowering individuals to take control of their health.

Advancements in big data analytics and artificial intelligence (AI) are enabling consumer genomics companies to extract valuable insights from vast genomic datasets, identify disease associations, and predict individual health risks with greater accuracy and specificity. Machine learning algorithms can analyze genetic variations, biomarkers, and clinical data to generate personalized risk assessments, treatment recommendations, and lifestyle interventions tailored to individual genetic profiles.

Key Market Challenges

Navigating Regulatory Landscape

One of the foremost challenges hindering the Global Consumer Genomics Market is navigating the complex regulatory landscape governing genetic testing and data privacy. Regulatory frameworks vary significantly across different regions and countries, creating compliance challenges for consumer genomics companies operating in multiple jurisdictions. The evolving nature of regulations, particularly regarding the classification and oversight of genetic tests by regulatory agencies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in the European Union, adds further complexity and uncertainty to market entry and expansion efforts.

Ensuring Data Privacy and Security

Data privacy and security concerns pose significant challenges to the Global Consumer Genomics Market, as the collection, storage, and analysis of genetic data raise ethical and legal considerations regarding the confidentiality and protection of sensitive information. Consumers are increasingly concerned about the risks of unauthorized access, misuse, or exploitation of their genetic data by third parties, including hacking, data breaches, and unauthorized sharing with employers, insurers, or law enforcement agencies. Consumer genomics companies must implement robust data encryption, access controls, and privacy policies to safeguard genetic information and earn the trust of consumers and regulatory authorities.

Addressing Ethical and Social Implications

The widespread adoption of consumer genomics raises ethical and social implications regarding the disclosure of genetic information, potential psychological impacts of genetic risk disclosures, and implications for personal identity, family relationships, and societal norms. Genetic testing results may reveal unexpected or sensitive information about individuals' health risks, ancestry, or paternity, leading to psychological distress, stigma, and discrimination. The commercialization of genetic data by testing companies and the commodification of genetic information raises concerns about equity, fairness, and societal implications of genetic profiling and discrimination based on genetic traits.

Key Market Trends

Technological Advancements

Over the past decade, there have been significant innovations in DNA sequencing techniques, leading to a dramatic reduction in sequencing costs, increased throughput, and improved accuracy. Next-generation sequencing (NGS) platforms have become more accessible and affordable, enabling consumer genomics companies to offer comprehensive genetic testing services at a fraction of the cost compared to traditional methods. Advancements in bioinformatics and data analysis algorithms are enhancing the interpretation of genetic data, providing more actionable insights into individuals' health risks, ancestry, and traits. Technological advancements are driving significant growth in the Global Consumer Genomics Market, revolutionizing the accessibility, affordability, and accuracy of genetic testing services. Over the past decade, breakthroughs in DNA sequencing technologies, particularly next-generation sequencing (NGS), have propelled the consumer genomics industry forward. NGS platforms have democratized access to genetic information by drastically reducing sequencing costs, increasing throughput, and improving scalability. This has enabled consumer genomics companies to offer comprehensive DNA testing services at lower prices, making genetic testing more accessible to a broader audience.

Advancements in bioinformatics and data analysis algorithms have enhanced the interpretation of genetic data, providing consumers with more actionable insights into their ancestry, health risks, and traits. Machine learning and artificial intelligence (AI) techniques are being increasingly utilized to analyze vast genomic datasets, identify disease associations, and predict individual health risks with greater accuracy and specificity. These technological advancements are driving innovation and expanding the scope of consumer genomics, paving the way for personalized healthcare solutions tailored to individual genetic profiles. As genomic technologies continue to evolve, consumer genomics is poised to play a pivotal role in shaping the future of preventive medicine, personalized healthcare, and wellness optimization on a global scale.

Expansion of Personalized Healthcare

The growing demand for personalized healthcare solutions is driving the expansion of the Global Consumer Genomics Market. With the rise of precision medicine and the increasing emphasis on preventive healthcare, consumers are seeking genetic testing services to gain insights into their genetic predispositions to diseases, response to medications, and optimal lifestyle choices. Consumer genomics companies are responding to this demand by diversifying their offerings to include a wide range of health and wellness-oriented genetic tests, including pharmacogenomics, nutrigenomics, and lifestyle assessments. This trend towards personalized healthcare is driving market growth and innovation, as consumers increasingly recognize the value of genetic information in optimizing their health and well-being. The expansion of personalized healthcare is a significant driver behind the growth of the Global Consumer Genomics Market. With the increasing emphasis on preventive medicine and the rise of precision healthcare, consumers are seeking genetic testing services to gain insights into their genetic predispositions to diseases, response to medications, and optimal lifestyle choices. This trend reflects a shift towards proactive health management, where individuals are empowered to take control of their health and make informed decisions based on their genetic makeup.

Consumer genomics companies are responding to this demand by diversifying their offerings to include a wide range of health and wellness-oriented genetic tests, including pharmacogenomics, nutrigenomics, and lifestyle assessments. By offering user-friendly DNA testing kits, online platforms for accessing genetic data, and personalized health reports, consumer genomics companies are empowering consumers to tailor their healthcare decisions to their unique genetic profiles. The expansion of personalized healthcare is driving market growth and innovation in the consumer genomics industry, as individuals increasingly recognize the value of genetic information in optimizing their health and well-being. As this trend continues to evolve, consumer genomics is poised to play a pivotal role in shaping the future of preventive medicine, personalized healthcare, and wellness optimization on a global scale.

Segmental Insights

Application Insights

Based on the application, genetic relatedness emerged as the dominant segment in the global consumer genomics market in 2023. This is due to the increasing consumer interest in understanding their genetic ancestry, familial relationships, and heritage. Consumers are intrigued by the prospect of uncovering their genetic roots and tracing their lineage through DNA testing, which has fueled the demand for ancestry and genealogy services offered by consumer genomics companies. Advancements in genetic sequencing technologies and data analytics have made it easier and more affordable for individuals to access and interpret their genetic information, further driving the growth of the Genetic Relatedness segment.

The lifestyle wellness & nutrition segment is anticipated to dominate the market in the forecast period on account of the growing consumer interest in personalized health and wellness solutions tailored to individual genetic profiles.

Regional Insights

North America emerged as the dominant player in the Global Consumer Genomics Market in 2023, holding the largest market share. This is primarily due to several factors contributing to the region's leadership in the consumer genomics industry. North America boasts a highly developed healthcare infrastructure and a strong emphasis on personalized medicine, driving widespread adoption of genetic testing services among consumers. The presence of key market players, such as 23andMe, AncestryDNA, and MyHeritage, located in North America, has significantly contributed to the region's market dominance.

Key Market Players

Positive Biosciences Limited
DNA N U Ltd.
Helix, Inc.
23andMe, Inc.
MyHeritage Ltd.
Pathway
Veritas Technologies LLC
Illumina, Inc.
Xcode Life
Toolbox Genomics

Report Scope:

In this report, the Global Consumer Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Consumer Genomics Market, By Application:

Genetic Relatedness
Diagnostics
Lifestyle Wellness & Nutrition
Ancestry
Personalized Medicine & Pharmacogenetic Testing
Sports Nutrition & Health
Other Application Types

Consumer Genomics Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Consumer Genomics Market.

Available Customizations:

Global Consumer Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Consumer Genomics Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Application (Genetic Relatedness, Diagnostics, Lifestyle Wellness, & Nutrition, Ancestry, Personalized Medicine & Pharmacogenetic Testing, Sports Nutrition & Health, Other Application Types)
- 5.2.2. By Company (2023)
- 5.2.3. By Region
5.3. Market Map

6. North America Consumer Genomics Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Consumer Genomics Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Application
- 6.3.2. Mexico Consumer Genomics Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Application
- 6.3.3. Canada Consumer Genomics Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Application

7. Europe Consumer Genomics Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Consumer Genomics Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Application
- 7.3.2. Germany Consumer Genomics Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Application
- 7.3.3. United Kingdom Consumer Genomics Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Application
- 7.3.4. Italy Consumer Genomics Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Application
- 7.3.5. Spain Consumer Genomics Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Application

8. Asia-Pacific Consumer Genomics Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Consumer Genomics Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Application
- 8.3.2. India Consumer Genomics Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Application
- 8.3.3. South Korea Consumer Genomics Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Application
- 8.3.4. Japan Consumer Genomics Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Application
- 8.3.5. Australia Consumer Genomics Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Application

9. South America Consumer Genomics Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Consumer Genomics Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Application
- 9.3.2. Argentina Consumer Genomics Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Application
- 9.3.3. Colombia Consumer Genomics Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Application

10. Middle East and Africa Consumer Genomics Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Consumer Genomics Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Application
- 10.3.2. Saudi Arabia Consumer Genomics Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Application
- 10.3.3. UAE Consumer Genomics Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Positive Biosciences Limited
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. DNA N U Ltd.
14.3. Helix, Inc.
14.4. 23andMe, Inc.
14.5. MyHeritage Ltd.
14.6. Pathway
14.7. Veritas Technologies LLC
14.8. Illumina, Inc.
14.9. Xcode Life
14.10. Toolbox Genomics